Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

19.31
Delayed Data
As of 4:00pm ET
 -0.23 / -1.18%
Today’s Change
11.60
Today|||52-Week Range
24.57
+2.01%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close19.54
Today’s open19.55
Day’s range19.19 - 19.72
Volume353,076
Average volume (3 months)468,997
Market cap$737.3M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-137.92%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+254.19%
P/E ratioNM
Price/Sales7.26
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
MYOVMyovant Sciences Ltd-0.39-3.32%
ANIPANI Pharmaceuticals ...-1.39-2.39%
EDITEditas Medicine Inc+0.02+0.11%
AMAGAMAG Pharmaceuticals...-0.60-2.43%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs